Suppr超能文献

κ 阿片样物质信号在慢性疼痛和阿片类药物成瘾的交叉点。

Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

机构信息

Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA.

Shirley and Stefan Hatos Center for Neuropharmacology, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

Handb Exp Pharmacol. 2022;271:315-350. doi: 10.1007/164_2021_434.

Abstract

Pain is complex and is a unique experience for individuals in that no two people will have exactly the same physiological and emotional response to the same noxious stimulus or injury. Pain is composed of two essential processes: a sensory component that allows for discrimination of the intensity and location of a painful stimulus and an emotional component that underlies the affective, motivational, unpleasant, and aversive response to a painful stimulus. Kappa opioid receptor (KOR) activation in the periphery and throughout the neuroaxis modulates both of these components of the pain experience. In this chapter we focus on recent findings that KORs contribute to the emotional, aversive nature of chronic pain, including how expression in the limbic circuitry contributes to anhedonic states and components of opioid misuse disorder. While the primary focus is on preclinical pain models, we also highlight clinical or human research where there is strong evidence for KOR involvement in negative affective states associated with chronic pain and opioid misuse.

摘要

疼痛是复杂的,每个人的体验都是独特的,因为没有两个人会对相同的有害刺激或损伤产生完全相同的生理和情绪反应。疼痛由两个基本过程组成:一个感觉成分,用于区分疼痛刺激的强度和位置,一个情绪成分,是对疼痛刺激的情感、动机、不愉快和厌恶反应的基础。κ 阿片受体(KOR)在外周和整个神经轴中的激活调节疼痛体验的这两个成分。在本章中,我们重点介绍了最近的发现,即 KOR 有助于慢性疼痛的情绪、厌恶性质,包括在边缘回路中的表达如何导致快感缺失状态和阿片类药物滥用障碍的成分。虽然主要重点是临床前疼痛模型,但我们也强调了临床或人类研究中,有强有力的证据表明 KOR 参与与慢性疼痛和阿片类药物滥用相关的消极情感状态。

相似文献

1
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.
Handb Exp Pharmacol. 2022;271:315-350. doi: 10.1007/164_2021_434.
2
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
J Neurosci. 2019 May 22;39(21):4162-4178. doi: 10.1523/JNEUROSCI.0274-19.2019. Epub 2019 Mar 12.
3
Does the kappa opioid receptor system contribute to pain aversion?
Front Pharmacol. 2014 Nov 17;5:253. doi: 10.3389/fphar.2014.00253. eCollection 2014.
4
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
J Neurosci. 2015 Sep 16;35(37):12917-31. doi: 10.1523/JNEUROSCI.2444-15.2015.
5
Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.
Neuropharmacology. 2020 Nov 1;178:108226. doi: 10.1016/j.neuropharm.2020.108226. Epub 2020 Aug 6.
6
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Int Rev Neurobiol. 2017;136:53-88. doi: 10.1016/bs.irn.2017.08.001. Epub 2017 Sep 12.
7
Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.
Neuropsychopharmacology. 2013 Dec;38(13):2623-31. doi: 10.1038/npp.2013.171. Epub 2013 Jul 18.
8
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Neurochem Int. 2019 Oct;129:104504. doi: 10.1016/j.neuint.2019.104504. Epub 2019 Jul 10.
9
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
J Neurosci. 2018 Sep 12;38(37):8031-8043. doi: 10.1523/JNEUROSCI.0653-18.2018. Epub 2018 Aug 3.
10
Learned avoidance requires VTA KOR-mediated reductions in dopamine.
Neuropharmacology. 2020 May 1;167:107996. doi: 10.1016/j.neuropharm.2020.107996. Epub 2020 Feb 11.

引用本文的文献

1
Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.
CNS Drugs. 2025 Jun;39(6):565-581. doi: 10.1007/s40263-025-01172-w. Epub 2025 Apr 1.
3
Unveiling the link between chronic pain and misuse of opioids and cannabis.
J Neural Transm (Vienna). 2024 May;131(5):563-580. doi: 10.1007/s00702-024-02765-3. Epub 2024 Apr 3.
4
Endogenous opioid systems alterations in pain and opioid use disorder.
Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022.
5
A Theoretical Endogenous Opioid Neurobiological Framework for Co-occurring Pain, Trauma, and Non-suicidal Self-injury.
Curr Pain Headache Rep. 2022 Jun;26(6):405-414. doi: 10.1007/s11916-022-01043-9. Epub 2022 Apr 5.
7
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.
Adv Drug Alcohol Res. 2021;1. doi: 10.3389/adar.2021.10009. Epub 2021 Aug 3.

本文引用的文献

1
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.
Neurotherapeutics. 2020 Jul;17(3):846-860. doi: 10.1007/s13311-020-00905-7.
3
Input-output connections of LJA5 prodynorphin neurons.
J Comp Neurol. 2021 Feb;529(3):635-654. doi: 10.1002/cne.24974. Epub 2020 Jul 24.
5
Changes in opioid receptors, opioid peptides and morphine antinociception in mice subjected to early life stress.
Eur J Pharmacol. 2020 Aug 15;881:173173. doi: 10.1016/j.ejphar.2020.173173. Epub 2020 Jun 5.
6
General anesthetics activate a potent central pain-suppression circuit in the amygdala.
Nat Neurosci. 2020 Jul;23(7):854-868. doi: 10.1038/s41593-020-0632-8. Epub 2020 May 18.
7
Endogenous opioid peptides in the descending pain modulatory circuit.
Neuropharmacology. 2020 Aug 15;173:108131. doi: 10.1016/j.neuropharm.2020.108131. Epub 2020 May 15.
8
Divergent Neural Pathways Emanating from the Lateral Parabrachial Nucleus Mediate Distinct Components of the Pain Response.
Neuron. 2020 Jun 17;106(6):927-939.e5. doi: 10.1016/j.neuron.2020.03.014. Epub 2020 Apr 13.
10
Amygdala, neuropeptides, and chronic pain-related affective behaviors.
Neuropharmacology. 2020 Jun 15;170:108052. doi: 10.1016/j.neuropharm.2020.108052. Epub 2020 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验